Dr. Skubitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
424 Harvard Street Se
Masonic Cancer Center, First Floor, Suite M100
Minneapolis, MN 55455Phone+1 612-676-4200Fax+1 612-626-1441- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1982 - 1983
- Johns Hopkins University School of MedicineFellowship, Clinical Pharmacology, 1979 - 1981
- University of MinnesotaResidency, Internal Medicine, 1976 - 1979
- Johns Hopkins University School of MedicineClass of 1976
Certifications & Licensure
- MN State Medical License 1978 - 2025
- MD State Medical License 1980 - 1983
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Start of enrollment: 2014 Jun 13
Publications & Presentations
PubMed
- 62 citationsResults of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L. Samuels, Sant P. Chawla, Neeta Somaiah, Arthur P. Staddon, Keith M. Skubitz
Cancer. 2017-12-01 - 118 citationsDenosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.Sant P. Chawla, Jean-Yves Blay, Piotr Rutkowski, Axel Le Cesne, Peter Reichardt
The Lancet. Oncology. 2019-12-01 - 375 citationsSafety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase ...Sant P. Chawla, Robert M. Henshaw, Leanne L. Seeger, Edwin Choy, Jean-Yves Blay
The Lancet. Oncology. 2013-08-01
Grant Support
- IL 2 Liposomes In Lung CancerNational Center For Research Resources1997–2000
- A Pilot Study Of Continuous Infusion Taxol For Refractory MalignanciesNational Center For Research Resources1996–1997
- Granulocyte Membrane Structure And FunctionNational Cancer Institute1985–1989
- Granulocyte Membrane Structure &FunctionNational Cancer Institute1987–1988
Professional Memberships
- Member
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: